Back to Search
Start Over
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in
- Source :
- Clinical cancer research : an official journal of the American Association for Cancer Research. 24(9)
- Publication Year :
- 2017
- Subjects :
- Adult
Male
Class I Phosphatidylinositol 3-Kinases
Genital Neoplasms, Female
Breast Neoplasms
Middle Aged
Pyrimidines
Treatment Outcome
Area Under Curve
Mutation
Biomarkers, Tumor
Humans
Female
Pyrroles
Molecular Targeted Therapy
Neoplasm Metastasis
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-akt
Aged
Neoplasm Staging
Subjects
Details
- ISSN :
- 15573265
- Volume :
- 24
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- Clinical cancer research : an official journal of the American Association for Cancer Research
- Accession number :
- edsair.pmid..........f9acd74e189fd6e03233b7508787b5c1